Rachel Harrison

Rachel Harrison

Company: Argenx

Job title: Director, Pre-Approval, Post-Trial Access Programmes, Medical Affairs & Evidence Generation

Seminars:

Workshop C: Transitioning to Commercial Teams for Launch 1:45 pm

Passing the baton to commercial colleagues Coordinating with cross-functional internal teams on final dispatch of drug supply, informing sites of upcoming launch, notifying Regulatory Authorities of cohort programme closure Introducing MSLs to the sites for a smooth transitionRead more

day: Pre-Conference Day Track 1 Afternoon

Rapid Fire Solutions: Tackling Real-World EAP Challenges 8:30 am

From patient burden to last-minute formulation changes, this fast-paced session delivers practical, on-the-ground solutions to common EAP challenges. Featuring a series of concise, ten-minute spotlights from leading biopharma, each presentation highlights a single innovation or tactic that helped unlock access, streamline processes, or support patient continuity. Designed to fuel actionable discussion, this session goes beyond…Read more

day: Day 1

Chair’s Opening Remarks 7:20 am

Read more

day: Day 2

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.